Subscribe
Machinery & Materials
Markets
Logistics & Cold Chain
Newsletters
PDA
More from PDA
Take Five
Digital Transformation Breakdown at the 2021 PDA Annual Meeting
The benefits of data collection, management techniques, and practices took center stage in a number of sessions at the 2021 Parenteral Drug Administration Annual Meeting. Learn about the latest developments from PDA's meeting in this Take Five video.
Regulatory
PDA Post-Approval Change Issues and Impacts Survey
This comprehensive survey includes data on the challenges presented by inconsistencies in how regulators treat post-approval changes and respondents’ experience with specific regulators.
Machinery & materials
Take PDA's COVID-19 Survey in Pharmaceuticals
The Parenteral Drug Association (PDA) is conducting an important assessment to understand industry impacts on operations and supply chains.
Home
PDA’s First Drug Delivery Innovation Award Winners at 2019 Universe of Pre-Filled Syringes and Injection Devices Conference
One award winner includes a thinner needle to reduce injection pain, while a partnership resulted in a precise microliter dosing syringe.
Home
Particles in Parenterals: 2019 Update
FDA expects a visual inspection program and parenteral manufacturers should expect questions about their program during any inspection. What's new in 2019?
Regulatory
Particles in Parenterals: 2019 Update
FDA expects a visual inspection program and parenteral manufacturers should expect questions about their program during any inspection. What's new in 2019?
Home
PDA Quality Culture Assessment
How can you “measure” the culture at your organization, or that of potential partner? PDA developed a tool to evaluate quality culture and a case study for training, built on the premise of a firm evaluating a potential CMO.
Home
PDA Container Closure Performance and Integrity Conference in June
At the event in Bethesda, MD, exchange ideas with industry peers and regulatory experts on meeting packaging demands for new medicines, novel delivery devices, and evolving regulations.
Regulatory
Data Integrity Code of Conduct
While the FDA asks pharma companies to heed its warnings around good manufacturing practices, the Parenteral Drug Association outlines actions to take.